Physician

Eric L Wallace, D.O.

According to 2025 Medicare claims, Eric Wallace, D.O. (NPI: 1568658243) practices interventional cardiology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is KOOTENAI HEALTH, INC. (NPI: 1174661151; TIN: 820380784) and primary practice location at 83814-6051. Wallace is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), AdvantagePoint Health Alliance - Northwest, LLC (ACO ID: A5025), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Wallace's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,961 traditional Medicare patients, billed 3,975 HCPCS/CPT codes, and received $224,099 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,669 prescription claims across 637 beneficiaries totaling $838,613 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 24 claims. Open Payments data shows 25 records totaling $27,655. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $15,535 to $838,613. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,886 to $1,415.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	555	1,241	$68,920
2016	1,292	3,139	$192,491
2017	1,835	4,102	$231,282
2018	1,609	3,579	$218,991
2019	1,600	3,523	$208,913
2020	1,400	2,970	$187,192
2021	1,991	4,005	$221,700
2022	1,853	3,650	$195,758
2023	1,961	3,808	$213,710
2024	1,961	3,975	$224,099

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	71	306	$15,535
2016	227	1,805	$98,518
2017	353	3,005	$206,961
2018	415	3,411	$267,463
2019	448	3,302	$322,572
2020	481	3,305	$384,255
2021	660	3,893	$560,727
2022	673	3,965	$770,240
2023	670	3,868	$871,734
2024	637	3,669	$838,613

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	38	$1,034
2019	N/R	24	$781
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	396	430	$76
93880	Ultrasound of both sides of head and neck blood flow	158	158	$49
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	678	705	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	205	218	$12
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	435	502	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	236	16,232	$310,639
Xarelto	Rivaroxaban	143	9,609	$177,735
Entresto	Sacubitril/Valsartan	63	4,361	$90,483
Repatha Sureclick	Evolocumab	70	4,648	$87,435
Jardiance	Empagliflozin	33	2,310	$42,476

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$697	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$26,959	Boehringer Ingelheim International GmbH
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Eric L. Wallace, D.O.?

Tedicare shows public-source Medicare data for Eric L. Wallace, D.O. (NPI 1568658243), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric L. Wallace, D.O. have ACO affiliation data?

Eric L. Wallace, D.O. is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), AdvantagePoint Health Alliance - Northwest, LLC (MSSP, ACO ID A5025), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Eric L. Wallace, D.O.?

Eric L. Wallace, D.O. is linked to KOOTENAI HEALTH, INC. (billing NPI 1174661151) in the available physician profile data.

Does Eric L. Wallace, D.O. have Open Payments data?

Eric L. Wallace, D.O. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.